白云(yun)山7月19日晚發布澄清公(gong)(gong)告稱，關注到最近有媒體報(bao)道涉及公(gong)(gong)司(si)控(kong)股(gu)(gu)股(gu)(gu)東(dong)廣(guang)(guang)藥(yao)(yao)集團、公(gong)(gong)司(si)及下屬(shu)企業。經核實(shi)，公(gong)(gong)司(si)分公(gong)(gong)司(si)白云(yun)山制藥(yao)(yao)總廠、白云(yun)山化學制藥(yao)(yao)廠，控(kong)股(gu)(gu)子公(gong)(gong)司(si)白云(yun)山醫藥(yao)(yao)科技公(gong)(gong)司(si)一直(zhi)依(yi)法依(yi)規進行經營，不存在虛增成本(ben)、偷稅(shui)漏稅(shui)、隱瞞收入、信息披露(lu)不實(shi)、侵害(hai)股(gu)(gu)東(dong)利益等情況(kuang)。相(xiang)關報(bao)道主要內容與事(shi)實(shi)不符。公(gong)(gong)司(si)接獲控(kong)股(gu)(gu)股(gu)(gu)東(dong)廣(guang)(guang)藥(yao)(yao)集團通知，廣(guang)(guang)藥(yao)(yao)集團已就相(xiang)關情況(kuang)向公(gong)(gong)安機關報(bao)案。